血清VEGF-C、VEGFR-2、3表达水平在急性白血病疗效监测及预后判断中的应用
Application of Serum VEGF-C,VEGFR-2 and VEGFR-3 Expression Level in Monitoring Curative Effects and Prognosis of Acute Leukemia
-
摘要: 目的 观察AL患者血清中VEGF-C及VEGFR-2、VEGFR-3表达水平,探讨其临床意义.方法采用酶联免疫吸附法对51例确诊为AL患者、接受治疗观察的43例及16例健康献血者血清中VEGF-C、VEGFR-2、3进行检测.结果 (1)AL患者VEGF-C、VEGFR-2及VEGFR-3水平,较正常对照组高,差异有统计学意义(P<0.01);(2)治疗后完全缓解(CR)组患者VEGF-C和VEGFR-2水平较治疗前降低,差异有统计学意义(P<0.01);治疗后未完全缓解(NR)组患者VEGF-C和VEGFR-2水平较治疗前降低,但差异无统计学意义(P>0.05);(3)治疗后CR组和NR组VEGFR-3水平较治疗前无明显变化(P>0.05);(4)治疗前NR组VEGFR-2、VEGFR-3水平明显高于CR组,具有统计学意义(P<0.01).结论 观察AL患者治疗前后VEGF-C及VEGFR-2、3表达水平,对预后判断、疗效评估和病情监测具有重要临床意义.
-
关键词:
- 急性白血病 /
- 血管内皮生长因子 /
- 血管内皮生长因子受体 /
- 酶联免疫吸附法
Abstract: Objective To observe expression level of serum vascular endothelial growth factor-C(VEGF-C), VEGF-C receptor-2 and VEGF-C receptor-3 in patients with acute leukemia(AL) and to explore its clinical significance. Methods Enzyme-linked immuno sorbent assay(ELISA) was used to detect the serum expression levels of VEGF-C, VEGFR-2, and VEGFR-3 of 51 patients diagnosed with acute leukemia, 43 patients under medical treatment and 16 healthy blood donors.Results(1) Serum VEGF-C, VEGFR-2, and VEGFR-3 expression levels in AL patients were significantly higher than those in normal control group.(2) Serum VEGF-C and VEGFR-2 expression levels in complete remission(CR) group significantly declined after treatment.Serum VEGF-C and VEGFR-2 expression levels in non-complete remission(NR) group slightly declined after treatment but no significant difference was found(P>0.05).(3) No significant difference was found in serum VEGFR-3 expression levels both in CR group and NR group after treatment(P>0.05).(4) Serum VEGF-C,VEGFR-2, and VEGFR-3 expression levels in NR group were significantly higher than those in CR group before treatment(P<0.08). Conclusions Observing serum expression level of VEGF-C,VEGFR-2,and VEGFR-3 of AL patients may be helpful in monitoring curative effects and prognosis of acute leukemia. -
[1] [1]CHEN D,ZHANG Y J,ZHU K W,et al.A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma[J].Tumor Boil,2013,34(3):1895-1899. [2] [2]YANCOPOULOS G D,DAVIS S,GALE N W,et al.Vascular-specific growth factors and blood vessel formation[J].Nature,2000,407(6801):242-248. [3]许立生,王水,黄中晶,等.ER、PR、VEGF、CA15-3、CA125和CEA水平在乳腺癌预后判断中的临床意义[J].实用医学杂志,2012,21(28):3565-3567. [4]李素艳,谭林,覃蒙斌,等.人结肠癌组织中NIBP、VEGA及ICAM-1的表达及其意义[J].实用医学杂志,2015,14(31):2315-2318. [5]邓伟雄,汤勇才,张年伟,等.乳腺癌患者血清血管内皮生长因子水平与临床病理特征及新辅助化疗疗效的相关性[J].实用医学杂志,2015,18(31):2963-2965. [6]李志国,曹研,何丽,等.多发性骨髓瘤中PIEN蛋白及血管新生调控因子的表达及意义[J].临床检验杂志,2010,28(4):296-297. [7]陶英,浦权,刘薏芝,等.恶性血液病骨髓活检塑包切片血管新生和血管内皮生长因子表达的研究[J].现代中西医结合杂志,2011,20(3):274-288. [8] [8]DIAS S,SHMELKOV S V,LAM G,et al.VEGF(165)Promates survival of leukemic cells by HSP90-mediated induction of Bcl-2 expression and apoptosis inhibition[J].Blood,2002,99(7):2532-2540. [9] [9]RUAN J,LEONARD J P.Targeting angiogenesis a novel,rational therapeutic approach for non-Hodgkin lymphoma[J].Leuk Lymphoma,2009,50(5):679-681. [10] 张之南,沈悌.血液病治疗及疗效标准[M].第3版.北京:科学技术出版社,2007:103-134. [11]耿丛丛,申政磊,何文娴,等.急性白血病患者骨髓内皮祖细胞的变化与微血管密度的关系[J].昆明医科大学学报,2013,34(4):59-62. [12] [12]LOHELA M,BRY M,TAMMELA T,et al.VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.Curr Opin Cell Biol,2009,21(2):154-165. [13]王婷,王静,李强.急性白血病患者化疗前后IL-2 TNF-a及VEGF水平检测的临床意义[J].中国实验诊断学,2014,18(7):1160-1162. [14]陈颖,王瑾,刘元昉,等.急性白血病患者化疗前后外周血IL-2 TNF-a和VEGF水平变化及与临床预后关系[J].现代生物医学进展,2015,11(20):3892-3895. -
点击查看大图
计量
- 文章访问数: 2359
- HTML全文浏览量: 894
- PDF下载量: 45
- 被引次数: 0
下载:
